Legal & General Group Plc - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,000
-94.0%
13,943
-88.1%
0.00%
Q1 2022$84,000
-66.8%
117,219
+4.7%
0.00%
Q4 2021$253,000
-17.9%
111,932
+4.6%
0.00%
Q3 2021$308,000
+5.1%
107,045
+38.5%
0.00%
Q2 2021$293,000
+152.6%
77,315
+126.1%
0.00%
Q1 2021$116,000
+20.8%
34,202
+0.1%
0.00%
Q4 2020$96,000
+10.3%
34,176
-0.9%
0.00%
Q3 2020$87,000
-83.4%
34,501
-10.4%
0.00%
Q2 2020$523,000
+224.8%
38,515
+82.0%
0.00%
Q1 2020$161,000
-2.4%
21,159
-18.8%
0.00%
Q4 2019$165,000
+61.8%
26,0510.0%0.00%
Q3 2019$102,000
-7.3%
26,051
+14.6%
0.00%
Q2 2019$110,000
-19.7%
22,732
+35.4%
0.00%
Q1 2019$137,000
+47.3%
16,7940.0%0.00%
Q4 2018$93,000
+40.9%
16,794
+123.5%
0.00%
Q3 2018$66,000
-12.0%
7,5150.0%0.00%
Q2 2018$75,000
-5.1%
7,515
-9.0%
0.00%
Q1 2018$79,000
-52.7%
8,259
-25.6%
0.00%
Q4 2017$167,000
-25.8%
11,105
-3.6%
0.00%
Q3 2017$225,000
+58.5%
11,519
+19.1%
0.00%
Q2 2017$142,000
+71.1%
9,672
+8.0%
0.00%
Q1 2017$83,000
-14.4%
8,958
-4.3%
0.00%
Q4 2016$97,000
+155.3%
9,359
+116.5%
0.00%
Q3 2016$38,000
+18.8%
4,3220.0%0.00%
Q2 2016$32,000
-17.9%
4,3220.0%0.00%
Q1 2016$39,000
+225.0%
4,322
+348.3%
0.00%
Q4 2015$12,0009640.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders